492 related articles for article (PubMed ID: 22836900)
1. Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.
Goldman DR; Freund KB; McCannel CA; Sarraf D
Retina; 2013 Jan; 33(1):48-55. PubMed ID: 22836900
[TBL] [Abstract][Full Text] [Related]
2. Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.
Mantel I; Schalenbourg A; Zografos L
Am J Ophthalmol; 2012 May; 153(5):910-922.e2. PubMed ID: 22310077
[TBL] [Abstract][Full Text] [Related]
3. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Stangos AN; Gandhi JS; Nair-Sahni J; Heimann H; Pournaras CJ; Harding SP
Am J Ophthalmol; 2010 Nov; 150(5):666-73. PubMed ID: 20719300
[TBL] [Abstract][Full Text] [Related]
4. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability.
Sasahara M; Tsujikawa A; Musashi K; Gotoh N; Otani A; Mandai M; Yoshimura N
Am J Ophthalmol; 2006 Oct; 142(4):601-7. PubMed ID: 17011852
[TBL] [Abstract][Full Text] [Related]
5. Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy.
Musashi K; Tsujikawa A; Hirami Y; Otani A; Yodoi Y; Tamura H; Yoshimura N
Am J Ophthalmol; 2007 May; 143(5):883-885. PubMed ID: 17452180
[TBL] [Abstract][Full Text] [Related]
6. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Ueno C; Gomi F; Sawa M; Nishida K
Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
[TBL] [Abstract][Full Text] [Related]
7. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.
Tsujikawa A; Hirami Y; Nakanishi H; Ojima Y; Aikawa H; Tamura H; Otani A; Yoshimura N
Retina; 2007 Sep; 27(7):832-8. PubMed ID: 17891005
[TBL] [Abstract][Full Text] [Related]
8. Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.
Gemmy Cheung CM; Yeo I; Li X; Mathur R; Lee SY; Chan CM; Wong D; Wong TY
Am J Ophthalmol; 2013 Feb; 155(2):295-304.e1. PubMed ID: 23111181
[TBL] [Abstract][Full Text] [Related]
9. Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.
Mantel I; Uffer S; Zografos L
Am J Ophthalmol; 2009 Dec; 148(6):932-8.e1. PubMed ID: 19800613
[TBL] [Abstract][Full Text] [Related]
10. Predictable signs of benign course of polypoidal choroidal vasculopathy: based upon the long-term observation of non-treated eyes.
Okubo A; Arimura N; Abematsu N; Sakamoto T
Acta Ophthalmol; 2010 Jun; 88(4):e107-14. PubMed ID: 20337601
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelial detachment in polypoidal choroidal vasculopathy.
Tsujikawa A; Sasahara M; Otani A; Gotoh N; Kameda T; Iwama D; Yodoi Y; Tamura H; Mandai M; Yoshimura N
Am J Ophthalmol; 2007 Jan; 143(1):102-111. PubMed ID: 17101112
[TBL] [Abstract][Full Text] [Related]
12. Punctate hyperfluorescent spots associated with polypoidal choroidal vasculopathy on indocyanine green angiography.
Kim H; Lee JH; Kwon KY; Byeon SH; Lee SC; Lee CS
Ophthalmic Surg Lasers Imaging Retina; 2015 Apr; 46(4):423-7. PubMed ID: 25970862
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.
Kawamura A; Yuzawa M; Mori R; Haruyama M; Tanaka K
Acta Ophthalmol; 2013 Sep; 91(6):e474-81. PubMed ID: 23848133
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic polypoidal choroidal vasculopathy of the macula.
Moorthy RS; Lyon AT; Rabb MF; Spaide RF; Yannuzzi LA; Jampol LM
Ophthalmology; 1998 Aug; 105(8):1380-5. PubMed ID: 9709746
[TBL] [Abstract][Full Text] [Related]
15. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
Kimura S; Morizane Y; Hosokawa M; Shiode Y; Kawata T; Doi S; Matoba R; Hosogi M; Fujiwara A; Inoue Y; Shiraga F
Am J Ophthalmol; 2015 Apr; 159(4):683-9. PubMed ID: 25555798
[TBL] [Abstract][Full Text] [Related]
16. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P
Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157
[TBL] [Abstract][Full Text] [Related]
17. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy.
Cheng CK; Peng CH; Chang CK; Hu CC; Chen LJ
Retina; 2011 May; 31(5):846-56. PubMed ID: 21317837
[TBL] [Abstract][Full Text] [Related]
18. Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
Hikichi T; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R; Takami K
Am J Ophthalmol; 2010 Nov; 150(5):674-682.e1. PubMed ID: 20691424
[TBL] [Abstract][Full Text] [Related]
19. Polypoidal choroidal vasculopathy with large vascular network.
Tateiwa H; Kuroiwa S; Gaun S; Arai J; Yoshimura N
Graefes Arch Clin Exp Ophthalmol; 2002 May; 240(5):354-61. PubMed ID: 12073058
[TBL] [Abstract][Full Text] [Related]
20. Peripheral exudative hemorrhagic chorioretinopathy simulating choroidal melanoma in 173 eyes.
Shields CL; Salazar PF; Mashayekhi A; Shields JA
Ophthalmology; 2009 Mar; 116(3):529-35. PubMed ID: 19157563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
